THE SITUATION OF ANTIBIOTIC USE AND TREATMENT RESULTS IN PATIENTS WITH CHEST AND ABDOMINAL SURGICAL SITE INFECTIONS AT CA MAU GENERAL HOSPITAL IN 2020
Main Article Content
Abstract
Background: Surgical site infection is the most common type of hospital-acquired infection, which increases mortality and prolongs the duration of treatment. Objectives: To determine the proportion of antibiotics used and treatment results in patients with chest and abdominal surgical site infections at Ca Mau General Hospital in 2020-2021. Materials and methods: A cross-sectional descriptive study was conducted on patients diagnosed with chest and abdominal surgical site infections and treated at the General Surgery Department of Ca Mau General Hospital from June 2020 to May 2021. Results: Beta-lactams with increased activity were the main class of antibiotics used (75.4%), followed by 5-Nitroimidazole (57.8%). Metronidazole was the most used (38.9%); followed by Ampicilin - sulbactam (34.5%); Amoxicilin Clavulanic acid (10.2%). The mean duration of treatment was 7.4 ± 7.3 days. Treatment results: 94.8% cured, 3.0% improved and 2.0% unchanged, no deaths. Conclusion: The appropriate antibiotic proportion was 81.4%. Beta-lactams with increased activity were the most used class of antibiotics, accounting for 75.4%. Metronidazole was the most used, accounting for 38.9%. Treatment results are pretty good, with 94.8% of patients cured, no deaths. The mean duration of treatment was 7.4 ± 7.3 days.
Keywords
Antibiotics, chest and abdominal surgical site infections
Article Details
References
2. Nguyễn Việt Hùng (2008), “Đặc điểm dịch tễ học nhiễm khuẩn vết mổ và tình hình sử dụng kháng sinh ở bệnh nhân phẫu thuật tại một số bệnh viện tỉnh phía Bắc”,Tạp chí Y học thực hành.2, tr.48-52.
3. Phạm Văn Tân (2016), Nghiên cứu nhiễm khuẩn các vết mổ phẫu thuật tiêu hóa tại Khoa ngoại Bệnh viện Bạch Mai, Học viện Quân y.
4. Phạm Ngọc Trường (2018), Thực trạng nhiễm khuẩn vết mổ và yếu tố liên quan tại một số bệnh viện tuyến tỉnh và trung ương, Học viện Quân y.
5. Lê Anh Tuân (2017), Nghiên cứu thực trạng và một số yếu tố liên quan đến nhiễm khuẩn vết mổ bụng tại Bệnh viện Đa khoa tỉnh Sơn La, Học viện Quân y.
6. Alkaaki A., Al-Radi O.O., et al. (2019), “Surgical site infection following abdominal surgery: a prospective cohort study”, Can J Surg. 62(2), pp.111-117.
7. Bastola R., Parajuli P., Neupane A., (2017), “Surgical Site infections: Distribution Studies of Sample, Outcome and Antimicrobial Susceptibility Testing”, J Med Microb Diagn. 6(1).
8. Bawahal M.S., Al-Radhi H.K., Alghurais A.A., et al. (2017), “Antibiotics Used in Gastrointestinal Surgery Prophylaxis and Treatment of Postoperative Infection”, The Egyptian Journal of Hospital Medicine. 69(5), pp.2486-2492.
9. Călina D., Docea A.O., Rosu L., et al. (2016), “Antimicrobial resistance development following surgical site infections”, Molecular Medicine Reports. 15, pp.681-688.
10. Cang T. H., Tram T.H.N, Trung Q.V., et al. (2020), “Trends in the Use of Surgical Antibiotic Prophylaxis at a Provincial Hospital in Vietnam”, Arch Pharma Pract 2020. 11(1), pp. 32-39.
11. Keerthi N., et al. (2018), “Clinical efficacy of two anti-microbials (ceftriaxone and metronidazole) versus three antimicrobials (ceftriaxone, metronidazole and amikacin) in perforative peritonitis”, Int Surg J. 5(11), pp.3644-3650.
12. Khan F.U., Fang Y., Khan Z., et al. (2020), “Occurrence, associated risk factors, and treatment of surgical site infections in Pakistan”, European Journal of Inflammation. 18.
13. Lee G.J., Kyoung K.H., Kim K.H., et al. (2021), “Current status of initial antibiotic therapy and analysis of infections in patients with solitary abdominal trauma: a multicenter trial in Korea”, Annals of Surgical Treatment and Research. 100(2), pp.119-125.
14. Ling M.L., Apisarnthanarak A., Madriaga G., (2015), “The burden of healthcare associated infections in Southeast Asia: a systematic literature review and meta-analysis”, Clinical Infectious Diseases. 60(11), pp.1690-9.
15. World Health Organization (2016), Global guidelines for the prevention of surgical site infection, 2016., World Health Organization.